ImmunologyLife Science AlliancePeer-reviewed
Variable PD-1 glycosylation modulates the activity of immune checkpoint inhibitors
Chih-Wei Chu, Tomislav Čaval, Frederico Alisson‐Silva…·Flavio Schwarz
This study shows that PD-1 glycosylation variants affect the efficacy of immune checkpoint inhibitors and suggests personalized therapeutic approaches.
24 citations